Back

Empagliflozin to prevent post-operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery (EMPOAF), a randomized, double-blind, placebo-controlled trial

28 August 2026 (12:00 - 12:15)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award Session in Arrhythmias, Pacing, and Electrophysiology Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Maryam Aghakouchakzadeh

University of Tehran-, Tehran (Iran (Islamic Republic of))

3 More presentations in this session

Presentation thumbnail
Splanchnic circulatory failure drives vasovagal syncope: bioimpedance profiling of regional fluid shifts and dose-response characterisation of greater splanchnic nerve stimulation
Doctor M. Zuhair (London, GB)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance-based prediction of ventricular arrhythmic events in non-ischemic cardiomyopathy: derivation and external validation in the international multicenter IMPROVE-NICM Study
Doctor A. Latini (Rozzano, IT)
Abstract Slides Video
Presentation thumbnail
All-cause mortality in post–myocardial infarction patients with reduced LVEF with and without ICD therapy: insights from the PROFID study
Doctor T. Chiba (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award Session in Arrhythmias, Pacing, and Electrophysiology
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular outcomes of wearable device-detected atrial fibrillation after major non-cardiac surgery: a prospective cohort study
28 August 2026
thumbnail
Congress Presentation
Prevention of incident atrial fibrillation in type 2 diabetes: nationwide target trial emulation of SGLT2 inhibitors versus GLP-1 receptor agonists
28 August 2026
thumbnail
Congress Presentation
EMPagliflozin after Aortic Valve Replacement study: a randomized clinical trial
28 August 2026
thumbnail
Congress Presentation
The impact of dapagliflozin on left atrial functions and recurrence in non-diabetic patients in the early post-cryoablation period
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources